CIBC Bancorp USA’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$122K Buy
23,258
+2,677
+13% +$9.09K ﹤0.01% 1839
2026
Q1
$36.2K Buy
+20,581
New +$44.6K ﹤0.01% 1724
2025
Q3
$132K Buy
+43,041
New +$123K ﹤0.01% 1329

Other funds holding CLOV

CIBC Bancorp USA's CLOV Position: Q2 2026 in Review

CIBC Bancorp USA increased its Clover Health Investments (CLOV) stake by 13% in Q2 2026, buying an estimated $9.09K and bringing the position to 23,258 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #1839.

CIBC Bancorp USA first reported a position in CLOV in Q3 2025 and has held it in 3 quarters since. The position peaked at $132K in Q3 2025. 208 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • CIBC Bancorp USA held 23,258 shares of Clover Health Investments worth $122K as of Q2 2026.
  • CIBC Bancorp USA bought 2,677 Clover Health Investments shares in Q2 2026, an estimated $9.09K.
  • Clover Health Investments made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1839 holding.
  • CIBC Bancorp USA first reported a position in Clover Health Investments in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Clover Health Investments position peaked at $132K in Q3 2025.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.